These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22179944)

  • 21. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
    Nasu K; Terashima M; Habara M; Ko E; Ito T; Yokota D; Ishizuka S; Kurita T; Kimura M; Kinoshita Y; Asakura Y; Tsuchikane E; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2013 Jul; 6(7):746-55. PubMed ID: 23769651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).
    Simsek C; Garcia-Garcia HM; van Geuns RJ; Magro M; Girasis C; van Mieghem N; Lenzen M; de Boer S; Regar E; van der Giessen W; Raichlen J; Duckers HJ; Zijlstra F; van der Steen T; Boersma E; Serruys PW;
    EuroIntervention; 2012 Jun; 8(2):235-41. PubMed ID: 22717926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
    Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors underlying regression of coronary atheroma with potent statin therapy.
    Puri R; Nissen SE; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; St John J; Wolski K; Uno K; Kataoka Y; Nicholls SJ
    Eur Heart J; 2013 Jun; 34(24):1818-25. PubMed ID: 23644179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of chronic statin therapy on clinical presentation and underlying lesion morphology in patients undergoing percutaneous intervention: an ADAPT-DES IVUS substudy.
    Kadohira T; Mintz GS; Souza CF; Witzenbichler B; Metzger DC; Rinaldi MJ; Mazzaferri EL; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Crowley A; Kirtane AJ; Stone GW; Maehara A
    Coron Artery Dis; 2017 May; 28(3):218-224. PubMed ID: 28240675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and evolution of thin-capped fibroatheromas in left main coronary artery as assessed by serial virtual histology intravascular ultrasound analysis.
    Kim SW; Mintz GS; Weissman NJ; Lee WS; Senguttuvan NB; Kwon JE; Kim H; Seo JS; Seok JW; Kim EY; Hyeon SH; Hong JH; Kim CJ; Cho DY; Kim TH
    J Invasive Cardiol; 2014 Apr; 26(4):175-9. PubMed ID: 24717275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study of the month: ASTEROID: regression of coronary atherosclerosis with rosuvastatin at a maximal daily dose of 40 mg].
    Scheen AJ
    Rev Med Liege; 2006 Apr; 61(4):267-72. PubMed ID: 16789616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of nonculprit coronary atherosclerotic plaques assessed by serial virtual histology intravascular ultrasound in patients with ST-segment elevation myocardial infarction and chronic total occlusion.
    Kang J; Jeon KH; Kim SW; Park JJ; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
    Coron Artery Dis; 2016 Dec; 27(8):650-657. PubMed ID: 27501406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and design for a study using intravascular ultrasound to evaluate effects of rosuvastatin on coronary artery atheroma in Japanese subjects: COSMOS study (Coronary Atherosclerosis Study Measuring Effects of Rosuvastatin Using Intravascular Ultrasound in Japanese Subjects).
    Takayama T; Hiro T; Yamagishi M; Daida H; Saito S; Yamaguchi T; Matsuzaki M
    Circ J; 2007 Feb; 71(2):271-5. PubMed ID: 17251680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries.
    Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Lenzen MJ; Simsek C; de Boer SP; Van Mieghem NM; Regar E; de Jaegere PP; Akkerhuis KM; Ligthart JM; Zijlstra F; Serruys PW; Boersma E
    EuroIntervention; 2016 Aug; 12(6):734-9. PubMed ID: 27542785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship Between Platelet Reactivity and Culprit Lesion Morphology: An Assessment From the ADAPT-DES Intravascular Ultrasound Substudy.
    Yun KH; Mintz GS; Witzenbichler B; Inaba S; Shimizu T; Metzger DC; Rinaldi MJ; Mazzaferri EL; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Kirtane AJ; Stone GW; Maehara A
    JACC Cardiovasc Imaging; 2016 Jul; 9(7):849-854. PubMed ID: 26897675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serial Assessment of Tissue Precursors and Progression of Coronary Calcification Analyzed by Fusion of IVUS and OCT: 5-Year Follow-Up of Scaffolded and Nonscaffolded Arteries.
    Zeng Y; Tateishi H; Cavalcante R; Tenekecioglu E; Suwannasom P; Sotomi Y; Collet C; Nie S; Jonker H; Dijkstra J; Radu MD; Räber L; McClean DR; van Geuns RJ; Christiansen EH; Fahrni T; Koolen J; Onuma Y; Bruining N; Serruys PW
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1151-1161. PubMed ID: 28330651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atherosclerotic plaque composition and classification identified by coronary computed tomography: assessment of computed tomography-generated plaque maps compared with virtual histology intravascular ultrasound and histology.
    Obaid DR; Calvert PA; Gopalan D; Parker RA; Hoole SP; West NE; Goddard M; Rudd JH; Bennett MR
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):655-64. PubMed ID: 23960215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usual dose of simvastatin does not inhibit plaque progression and lumen loss at the peri-stent reference segments after bare-metal stent implantation: a serial intravascular ultrasound analysis.
    Hong YJ; Jeong MH; Choi YH; Ma EH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Korean J Intern Med; 2010 Dec; 25(4):356-63. PubMed ID: 21179272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of intensive lipid lowering on lipid profiles over time and tolerability in stable coronary artery disease: insights from a subanalysis of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
    Kawashiri MA; Yamagishi M; Sakamoto T; Takayama T; Hiro T; Daida H; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
    Cardiovasc Ther; 2013 Dec; 31(6):335-43. PubMed ID: 23409830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoprotein B, small-dense LDL and impaired HDL remodeling is associated with larger plaque burden and more noncalcified plaque as assessed by coronary CT angiography and intravascular ultrasound with radiofrequency backscatter: results from the ATLANTA I study.
    Voros S; Joshi P; Qian Z; Rinehart S; Vazquez-Figueroa JG; Anderson H; Elashoff M; Murrieta L; Karmpaliotis D; Kalynych A; Brown C; Schaefer E; Asztalos B
    J Am Heart Assoc; 2013 Nov; 2(6):e000344. PubMed ID: 24252842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deviation from Murray's law is associated with a higher degree of calcification in coronary bifurcations.
    Schoenenberger AW; Urbanek N; Toggweiler S; Seelos R; Jamshidi P; Resink TJ; Erne P
    Atherosclerosis; 2012 Mar; 221(1):124-30. PubMed ID: 22261173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproducibility of Shin's method for necrotic core and calcium content in atherosclerotic coronary lesions treated with bioresorbable everolimus-eluting vascular scaffolds using volumetric intravascular ultrasound radiofrequency-based analysis.
    Shin ES; Garcia-Garcia HM; Sarno G; Thuesen L; Dudek D; Ormiston JA; Serruys PW
    Int J Cardiovasc Imaging; 2012 Jan; 28(1):43-9. PubMed ID: 21229393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of statin therapy on the progression of coronary atherosclerosis.
    Tian J; Gu X; Sun Y; Ban X; Xiao Y; Hu S; Yu B
    BMC Cardiovasc Disord; 2012 Sep; 12():70. PubMed ID: 22938176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.